Clinician's Roundtable

Host: Brian P. McDonough, MD, FAAFP

Guest: David A. Lieberman, MD


Long-term effectiveness of colorectal cancer (CRC) screening depends on more than the performance of an individual test; it requires sustained adherence to recommended screening intervals and timely follow-up after abnormal results. But real-world data shows that many patients fall off track over time. Learn more about how we can improve adherence, reduce disparities, and strengthen continuity across the screening pathway as Dr. Brian McDonough sits down with Dr. David Lieberman, Professor Emeritus in the Department of Medicine and former Chief of the Division of Gastroenterology and Hepatology at Oregon Health & Science University in Portland.

Host: Shelina Ramnarine, PhD

Guest: Samuel Ubanyionwu, PharmD, EMBA


Accurate IV medication delivery depends on more than proper pump programming alone. It requires a comprehensive understanding of smart pump drug libraries, dose error reduction software (DERS), infusion mechanics, and system-level safety procedures. To explore how these elements work together to support IV medication accuracy, patient safety, and clinical decision-making, Dr. Shelina Ramnarine speaks with Dr. Samuel Ubanyionwu, Medication Management Informaticist in Pharmacy Services and an Assistant Professor of Pharmacy at the Mayo Clinic College of Medicine.

Guest: Sayna Norouzi, MD


Because patients with IgA nephropathy (IgAN) often have few symptoms early in the disease course, communicating the importance of treatment and its impacts on long-term outcomes can be challenging. Join Dr. Sayna Norouzi as she discusses practical communication techniques for explaining prognosis, setting expectations around therapy, and partnering with patients to support informed treatment decisions and long-term kidney health. Dr. Norouzi is an Associate Professor of Medicine and Clinical Nephrologist at Loma Linda University Medical Center in California. She's also the Founder and Director of the Glomerular Diseases Clinic at Loma Linda and Director of the GlomCon Glomerular Diseases Fellowship Program.

Guest: Anjay Rastogi, MD, PhD


Closer collaboration between nephrologists and pathologists is essential for optimizing the diagnosis and management of IgA nephropathy (IgAN). Hear from Dr. Anjay Rastogi as he highlights how pathology insights, clinical context, and ongoing communication can improve interpretation of kidney biopsy findings and support more informed treatment decisions. He's a Professor of Medicine and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, as well as the Director of the UCLA CORE Kidney Health Program.

Guest: Anjay Rastogi, MD, PhD


Managing IgA nephropathy (IgAN) is becoming increasingly complex. In this episode, Dr. Anjay Rastogi explains why an expert opinion—not simply a second opinion—can help clinicians confirm diagnoses, optimize treatment decisions, and connect appropriate patients with specialized care and emerging therapeutic opportunities. Dr. Rastogi is a Professor of Medicine and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA. He's also the Director of the UCLA CORE Kidney Health Program.